According to a novel study, a blood test that combines cognitive decline detection and memory loss detection has an amazing 90% accuracy rate in identifying memory loss as a result of Alzheimer’s disease. Compared to primary care physicians, who had an even lower success rate of 61%, and neurologists and other memory specialists, who properly...
Tag: ClinicalTrials
Post
New Genetic Insights into Cancer: The Importance of BAP1 Variants
Researchers have found over 5,000 genetic variants that dramatically accelerate the growth of different kinds of cancer in a ground-breaking study. In addition to identifying high-risk genetic variations, this study raises the possibility of new pharmacological targets for the successful treatment of certain cancer types. Prominent scientists from the University of Cambridge, the Wellcome Sanger...
Post
Revolutionizing HIV Prevention: The Promise of Lenacapavir Injections
The daily use of a pill such as Truvada has been a mainstay of the fight against HIV infections for over a decade. This kind of preventive medication, called pre-exposure prophylaxis, or PrEP, has demonstrated impressive efficacy in clinical trials, with up to 99% success rate in preventing new HIV infections that are contracted through...
Post
New NIH Trials Aim to Address HIV Inequities in Women and Intravenous Drug Users
On Tuesday, the National Institutes of Health (NIH) declared the commencement of two noteworthy clinical trials that are intended to assess the efficacy and safety of an HIV pre-exposure prophylaxis (PrEP) medication among marginalized demographic groups. This effort, which focuses on groups like women and intravenous drug users that have previously been underrepresented in clinical...